相关实验视频

Updated: Jun 20, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

HydraScreen:一种可推广的基于结构的深度学习方法来发现药物

Alvaro Prat¹, Hisham Abdel Aty¹, Orestis Bastas¹

¹AI Chemistry, Ro5 2801 Gateway Drive, Irving, 75063 Texas, United States.

Journal of chemical information and modeling

|July 22, 2024

概括

HydraScreen是一个深度学习框架,它使用3D卷积神经网络加速药物发现,用于蛋白质 - 连接体结合. 它在预测结合亲和力和姿势方面取得了最好的结果,提高了安全性和稳定性.

科学领域:

计算化学是一种计算化学.
药物发现药物发现
机器学习是机器学习.

背景情况:

加快药物发现需要强大的计算工具.
精确预测蛋白质 - 配体相互作用对于基于结构的药物设计至关重要.
现有的方法可能会面临偏见和概括的挑战.

研究的目的:

引入HydraScreen,这是一个深度学习框架,用于安全和强大的加速药物发现.
开发一个端到端的管道,用于高吞吐量选和线优化.
提高机器学习模型在药物发现中的可解释性和公正性.

主要方法:

利用最先进的3D卷积神经网络进行分子结构和相互作用表示.
实施了一个端到端的管道,用于高吞吐量选和线优化.
开发了一种新的交互分析方法来检测模型和数据偏差.

主要成果:

在CASF-2016对亲和力和姿势预测的基准上取得了顶级结果 (皮尔森的r = 0.86,RMSE = 1.15,Top-1 = 0.95).
通过时分裂,通过新型蛋白质和连接体进行有效的概括.
交互分析提高了解释性,加强了模型的公正性.

结论:

HydraScreen为加速药物发现提供了一个安全而强大的框架.
该框架在预测蛋白质-连接体结合方面表现强.
未来的工作可以专注于提高机器学习评分函数的稳定性.

更多相关视频

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...